Biheart-B (02185) said Giorgio Gobbi has joined its non-wholly owned subsidiary Shanghai Antong Medical Technology as vice president of global therapy development, where he will oversee global therapy development for the Iberis renal denervation system.

The company said Gobbi previously held senior management roles at Medtronic and ReCor Medical and has more than 20 years of experience in cardiovascular and metabolic diseases, according to ETNet.